The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Companion Diagnostic Technologies Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Companion Diagnostic Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Companion Diagnostic Technologies market size is estimated to be worth US$ 2851.5 million in 2021 and is forecast to a readjusted size of USD 5851.2 million by 2028 with a CAGR of 10.8% during review period. Oncology accounting for % of the Companion Diagnostic Technologies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunohistochemistry segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Companion Diagnostic Technologies include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Companion Diagnostic Technologies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunohistochemistry
Molecular Diagnostics
Market segment by Application, can be divided into
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
Market segment by players, this report covers
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Companion Diagnostic Technologies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Companion Diagnostic Technologies, with revenue, gross margin and global market share of Companion Diagnostic Technologies from 2019 to 2022.
Chapter 3, the Companion Diagnostic Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Companion Diagnostic Technologies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Companion Diagnostic Technologies research findings and conclusion, appendix and data source.
Geographical Area
Global
The Companion Diagnostic Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Companion Diagnostic Technologies market size is estimated to be worth US$ 2851.5 million in 2021 and is forecast to a readjusted size of USD 5851.2 million by 2028 with a CAGR of 10.8% during review period. Oncology accounting for % of the Companion Diagnostic Technologies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunohistochemistry segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Companion Diagnostic Technologies include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Companion Diagnostic Technologies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunohistochemistry
Molecular Diagnostics
Market segment by Application, can be divided into
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
Market segment by players, this report covers
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Companion Diagnostic Technologies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Companion Diagnostic Technologies, with revenue, gross margin and global market share of Companion Diagnostic Technologies from 2019 to 2022.
Chapter 3, the Companion Diagnostic Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Companion Diagnostic Technologies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Companion Diagnostic Technologies research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Technologies
1.2 Classification of Companion Diagnostic Technologies by Type
1.2.1 Overview: Global Companion Diagnostic Technologies Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Companion Diagnostic Technologies Revenue Market Share by Type in 2021
1.2.3 Immunohistochemistry
1.2.4 Molecular Diagnostics
1.3 Global Companion Diagnostic Technologies Market by Application
1.3.1 Overview: Global Companion Diagnostic Technologies Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Global Companion Diagnostic Technologies Market Size & Forecast
1.5 Global Companion Diagnostic Technologies Market Size and Forecast by Region
1.5.1 Global Companion Diagnostic Technologies Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Companion Diagnostic Technologies Market Size by Region, (2017-2022)
1.5.3 North America Companion Diagnostic Technologies Market Size and Prospect (2017-2028)
1.5.4 Europe Companion Diagnostic Technologies Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Companion Diagnostic Technologies Market Size and Prospect (2017-2028)
1.5.6 South America Companion Diagnostic Technologies Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Companion Diagnostic Technologies Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Companion Diagnostic Technologies Market Drivers
1.6.2 Companion Diagnostic Technologies Market Restraints
1.6.3 Companion Diagnostic Technologies Trends Analysis
2 Company Profiles
2.1 Dako (Agilent Technologies)
2.1.1 Dako (Agilent Technologies) Details
2.1.2 Dako (Agilent Technologies) Major Business
2.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Product and Solutions
2.1.4 Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Dako (Agilent Technologies) Recent Developments and Future Plans
2.2 Qiagen
2.2.1 Qiagen Details
2.2.2 Qiagen Major Business
2.2.3 Qiagen Companion Diagnostic Technologies Product and Solutions
2.2.4 Qiagen Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Qiagen Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Companion Diagnostic Technologies Product and Solutions
2.3.4 Roche Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Roche Recent Developments and Future Plans
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories Companion Diagnostic Technologies Product and Solutions
2.4.4 Abbott Laboratories Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Abbott Laboratories Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Product and Solutions
2.5.4 Thermo Fisher Scientific Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 bioMerieux
2.6.1 bioMerieux Details
2.6.2 bioMerieux Major Business
2.6.3 bioMerieux Companion Diagnostic Technologies Product and Solutions
2.6.4 bioMerieux Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 bioMerieux Recent Developments and Future Plans
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business
2.7.3 Myriad Genetics Companion Diagnostic Technologies Product and Solutions
2.7.4 Myriad Genetics Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Myriad Genetics Recent Developments and Future Plans
2.8 Resonance Health Ltd.
2.8.1 Resonance Health Ltd. Details
2.8.2 Resonance Health Ltd. Major Business
2.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Product and Solutions
2.8.4 Resonance Health Ltd. Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Resonance Health Ltd. Recent Developments and Future Plans
2.9 Leica Microsystems
2.9.1 Leica Microsystems Details
2.9.2 Leica Microsystems Major Business
2.9.3 Leica Microsystems Companion Diagnostic Technologies Product and Solutions
2.9.4 Leica Microsystems Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Leica Microsystems Recent Developments and Future Plans
2.10 Danaher
2.10.1 Danaher Details
2.10.2 Danaher Major Business
2.10.3 Danaher Companion Diagnostic Technologies Product and Solutions
2.10.4 Danaher Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Danaher Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Companion Diagnostic Technologies Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Companion Diagnostic Technologies Players Market Share in 2021
3.2.2 Top 10 Companion Diagnostic Technologies Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Companion Diagnostic Technologies Players Head Office, Products and Services Provided
3.4 Companion Diagnostic Technologies Mergers & Acquisitions
3.5 Companion Diagnostic Technologies New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Companion Diagnostic Technologies Revenue and Market Share by Type (2017-2022)
4.2 Global Companion Diagnostic Technologies Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Companion Diagnostic Technologies Revenue Market Share by Application (2017-2022)
5.2 Global Companion Diagnostic Technologies Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Companion Diagnostic Technologies Revenue by Type (2017-2028)
6.2 North America Companion Diagnostic Technologies Revenue by Application (2017-2028)
6.3 North America Companion Diagnostic Technologies Market Size by Country
6.3.1 North America Companion Diagnostic Technologies Revenue by Country (2017-2028)
6.3.2 United States Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
6.3.3 Canada Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
6.3.4 Mexico Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Companion Diagnostic Technologies Revenue by Type (2017-2028)
7.2 Europe Companion Diagnostic Technologies Revenue by Application (2017-2028)
7.3 Europe Companion Diagnostic Technologies Market Size by Country
7.3.1 Europe Companion Diagnostic Technologies Revenue by Country (2017-2028)
7.3.2 Germany Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
7.3.3 France Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
7.3.5 Russia Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
7.3.6 Italy Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Companion Diagnostic Technologies Revenue by Type (2017-2028)
8.2 Asia-Pacific Companion Diagnostic Technologies Revenue by Application (2017-2028)
8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Technologies Revenue by Region (2017-2028)
8.3.2 China Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
8.3.3 Japan Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
8.3.4 South Korea Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
8.3.5 India Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
8.3.7 Australia Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Companion Diagnostic Technologies Revenue by Type (2017-2028)
9.2 South America Companion Diagnostic Technologies Revenue by Application (2017-2028)
9.3 South America Companion Diagnostic Technologies Market Size by Country
9.3.1 South America Companion Diagnostic Technologies Revenue by Country (2017-2028)
9.3.2 Brazil Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
9.3.3 Argentina Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Companion Diagnostic Technologies Revenue by Type (2017-2028)
10.2 Middle East & Africa Companion Diagnostic Technologies Revenue by Application (2017-2028)
10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Technologies Revenue by Country (2017-2028)
10.3.2 Turkey Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
10.3.4 UAE Companion Diagnostic Technologies Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Companion Diagnostic Technologies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Companion Diagnostic Technologies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Companion Diagnostic Technologies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Companion Diagnostic Technologies Revenue (USD Million) by Region (2017-2022)
Table 5. Global Companion Diagnostic Technologies Revenue Market Share by Region (2023-2028)
Table 6. Dako (Agilent Technologies) Corporate Information, Head Office, and Major Competitors
Table 7. Dako (Agilent Technologies) Major Business
Table 8. Dako (Agilent Technologies) Companion Diagnostic Technologies Product and Solutions
Table 9. Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Qiagen Corporate Information, Head Office, and Major Competitors
Table 11. Qiagen Major Business
Table 12. Qiagen Companion Diagnostic Technologies Product and Solutions
Table 13. Qiagen Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Roche Corporate Information, Head Office, and Major Competitors
Table 15. Roche Major Business
Table 16. Roche Companion Diagnostic Technologies Product and Solutions
Table 17. Roche Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Abbott Laboratories Major Business
Table 20. Abbott Laboratories Companion Diagnostic Technologies Product and Solutions
Table 21. Abbott Laboratories Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Companion Diagnostic Technologies Product and Solutions
Table 25. Thermo Fisher Scientific Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. bioMerieux Corporate Information, Head Office, and Major Competitors
Table 27. bioMerieux Major Business
Table 28. bioMerieux Companion Diagnostic Technologies Product and Solutions
Table 29. bioMerieux Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 31. Myriad Genetics Major Business
Table 32. Myriad Genetics Companion Diagnostic Technologies Product and Solutions
Table 33. Myriad Genetics Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Resonance Health Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Resonance Health Ltd. Major Business
Table 36. Resonance Health Ltd. Companion Diagnostic Technologies Product and Solutions
Table 37. Resonance Health Ltd. Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Leica Microsystems Corporate Information, Head Office, and Major Competitors
Table 39. Leica Microsystems Major Business
Table 40. Leica Microsystems Companion Diagnostic Technologies Product and Solutions
Table 41. Leica Microsystems Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Danaher Corporate Information, Head Office, and Major Competitors
Table 43. Danaher Major Business
Table 44. Danaher Companion Diagnostic Technologies Product and Solutions
Table 45. Danaher Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Companion Diagnostic Technologies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Companion Diagnostic Technologies Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Companion Diagnostic Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Companion Diagnostic Technologies Players Head Office, Products and Services Provided
Table 50. Companion Diagnostic Technologies Mergers & Acquisitions in the Past Five Years
Table 51. Companion Diagnostic Technologies New Entrants and Expansion Plans
Table 52. Global Companion Diagnostic Technologies Revenue (USD Million) by Type (2017-2022)
Table 53. Global Companion Diagnostic Technologies Revenue Share by Type (2017-2022)
Table 54. Global Companion Diagnostic Technologies Revenue Forecast by Type (2023-2028)
Table 55. Global Companion Diagnostic Technologies Revenue by Application (2017-2022)
Table 56. Global Companion Diagnostic Technologies Revenue Forecast by Application (2023-2028)
Table 57. North America Companion Diagnostic Technologies Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Companion Diagnostic Technologies Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Companion Diagnostic Technologies Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Companion Diagnostic Technologies Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Companion Diagnostic Technologies Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Companion Diagnostic Technologies Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Companion Diagnostic Technologies Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Companion Diagnostic Technologies Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Companion Diagnostic Technologies Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Companion Diagnostic Technologies Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Companion Diagnostic Technologies Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Companion Diagnostic Technologies Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Companion Diagnostic Technologies Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Companion Diagnostic Technologies Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Companion Diagnostic Technologies Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Companion Diagnostic Technologies Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Companion Diagnostic Technologies Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Companion Diagnostic Technologies Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Companion Diagnostic Technologies Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Companion Diagnostic Technologies Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Companion Diagnostic Technologies Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Companion Diagnostic Technologies Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Companion Diagnostic Technologies Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Companion Diagnostic Technologies Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Companion Diagnostic Technologies Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Companion Diagnostic Technologies Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Companion Diagnostic Technologies Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Companion Diagnostic Technologies Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Companion Diagnostic Technologies Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Companion Diagnostic Technologies Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Companion Diagnostic Technologies Picture
Figure 2. Global Companion Diagnostic Technologies Revenue Market Share by Type in 2021
Figure 3. Immunohistochemistry
Figure 4. Molecular Diagnostics
Figure 5. Companion Diagnostic Technologies Revenue Market Share by Application in 2021
Figure 6. Oncology Picture
Figure 7. Cardiovascular Picture
Figure 8. Central Nervous System Picture
Figure 9. Auto immune & Inflammation Picture
Figure 10. Virology Picture
Figure 11. Others Picture
Figure 12. Global Companion Diagnostic Technologies Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Companion Diagnostic Technologies Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Companion Diagnostic Technologies Revenue Market Share by Region (2017-2028)
Figure 15. Global Companion Diagnostic Technologies Revenue Market Share by Region in 2021
Figure 16. North America Companion Diagnostic Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Companion Diagnostic Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Companion Diagnostic Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Companion Diagnostic Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Companion Diagnostic Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Companion Diagnostic Technologies Market Drivers
Figure 22. Companion Diagnostic Technologies Market Restraints
Figure 23. Companion Diagnostic Technologies Market Trends
Figure 24. Dako (Agilent Technologies) Recent Developments and Future Plans
Figure 25. Qiagen Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Abbott Laboratories Recent Developments and Future Plans
Figure 28. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 29. bioMerieux Recent Developments and Future Plans
Figure 30. Myriad Genetics Recent Developments and Future Plans
Figure 31. Resonance Health Ltd. Recent Developments and Future Plans
Figure 32. Leica Microsystems Recent Developments and Future Plans
Figure 33. Danaher Recent Developments and Future Plans
Figure 34. Global Companion Diagnostic Technologies Revenue Share by Players in 2021
Figure 35. Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Companion Diagnostic Technologies Revenue Market Share in 2021
Figure 37. Global Top 10 Players Companion Diagnostic Technologies Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Companion Diagnostic Technologies Revenue Share by Type in 2021
Figure 40. Global Companion Diagnostic Technologies Market Share Forecast by Type (2023-2028)
Figure 41. Global Companion Diagnostic Technologies Revenue Share by Application in 2021
Figure 42. Global Companion Diagnostic Technologies Market Share Forecast by Application (2023-2028)
Figure 43. North America Companion Diagnostic Technologies Sales Market Share by Type (2017-2028)
Figure 44. North America Companion Diagnostic Technologies Sales Market Share by Application (2017-2028)
Figure 45. North America Companion Diagnostic Technologies Revenue Market Share by Country (2017-2028)
Figure 46. United States Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Companion Diagnostic Technologies Sales Market Share by Type (2017-2028)
Figure 50. Europe Companion Diagnostic Technologies Sales Market Share by Application (2017-2028)
Figure 51. Europe Companion Diagnostic Technologies Revenue Market Share by Country (2017-2028)
Figure 52. Germany Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Companion Diagnostic Technologies Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Companion Diagnostic Technologies Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Companion Diagnostic Technologies Revenue Market Share by Region (2017-2028)
Figure 60. China Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Companion Diagnostic Technologies Sales Market Share by Type (2017-2028)
Figure 67. South America Companion Diagnostic Technologies Sales Market Share by Application (2017-2028)
Figure 68. South America Companion Diagnostic Technologies Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Companion Diagnostic Technologies Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Companion Diagnostic Technologies Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Companion Diagnostic Technologies Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Companion Diagnostic Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
